๐๏ธ Verified NIH Record โข Updated 2026-07-30
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy (NCT06018558)
A Phase 1/2 Study to Assess the Safety And Efficacy Of OCU410 For Geographic Atrophy Secondary To Dry Age-Related Macular Degeneration
๐ต Active, Not Recruiting Phase1 / Phase2 ๐ Clinical Research Protocol Sponsor: Ocugen
๐ฉบ Plain-English Summary (8th-Grade Level)
This is a Phase 1/2 Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration (AMD). This is a multicenter study, which will be conducted in two phases and will enroll up to a total of 60 subjects.
Who can join: Review the eligibility criteria below.
Location: Associated Retina Consultants โ Phoenix, Arizona
Age range: 50 Years
๐งช Interventions in This Study
- OCU410 (GENETIC)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (12 Sites)
- Associated Retina Consultants โ Phoenix, Arizona
- Advanced Research, LLC โ Coral Springs, Florida
- Miidwest Eye Institute โ Carmel, Indiana
- Mississippi Retina Associates โ Jackson, Mississippi
- The Retina Institute โ St Louis, Missouri
- Mid Atlantic Retina โ Cherry Hill, New Jersey
- Duke Eye Center โ Durham, North Carolina
- The University of Pittsburgh โ Pittsburgh, Pennsylvania
- B) Retina Consultants of Texas โ Bellaire, Texas
- A) Retina Foundation of the Southwest โ Dallas, Texas
- Valley retina Institute โ McAllen, Texas
- Gundersen Health System โ La Crosse, Wisconsin
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Geographic Atrophy
- A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) โ Scottsdale, Arizona
- A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration โ Bakersfield, California
- Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy โ Phoenix, Arizona
- A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy โ Gilbert, Arizona
- A Study in Adults With Geographic Atrophy โ Bakersfield, California
Explore by condition: All Geographic Atrophy clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.